Becton Dickinson Profit Margin 2006-2018 | BDX

Current and historical gross margin, operating margin and net profit margin for Becton Dickinson (BDX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Becton Dickinson net profit margin as of December 31, 2018 is 5.69%.
Becton Dickinson Annual Profit Margins
Becton Dickinson Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $60.773B $15.983B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
Align Technology (ALGN) United States $21.893B 55.74
McKesson (MCK) United States $21.578B 8.40
AmerisourceBergen (ABC) United States $15.262B 11.07
Laboratory Of America Holdings (LH) United States $14.225B 13.08
Cooper (COO) United States $13.790B 24.06
Cardinal Health (CAH) United States $13.375B 9.01
DENTSPLY SIRONA (XRAY) United States $10.910B 24.26
Henry Schein (HSIC) United States $9.077B 14.67
West Pharmaceutical Services (WST) United States $8.232B 39.73
Merit Medical Systems (MMSI) United States $3.178B 34.20
CONMED (CNMD) United States $2.210B 35.90
Patterson (PDCO) United States $1.999B 15.79
Atrion (ATRI) United States $1.600B 46.96
STAAR Surgical (STAA) United States $1.420B 118.96
Antares Pharma (ATRS) United States $0.435B 0.00
Invacare (IVC) United States $0.229B 0.00
Lifevantage (LFVN) United States $0.158B 21.25
Pro-Dex (PDEX) United States $0.062B 28.36
Endologix (ELGX) United States $0.061B 0.00
Biolase (BIOL) United States $0.045B 0.00
Retractable Technologies (RVP) United States $0.021B 0.00
Milestone Scientific (MLSS) United States $0.015B 0.00